The relationship between awareness and supplementation: which Canadian women know about folic acid and how does that translate into use?
Nelson, Chantal R.M. ; Leon, Juan Andres ; Evans, Jane 等
The rate of neural tube defects (NTD) in Canada has declined
significantly after the 1998 mandatory introduction of folic acid (FA)
fortification of many food grain products, from a rate of 5.5 per 10,000
births in 1996 to 4.1 per 10,000 births in 2007. (1) Despite this
fortification, a significant proportion of women of childbearing age
still have levels of red blood cell folate below optimal for protection
against NTD in their infants. (2) A diet including naturally folate-rich
and FA-fortified foods may still provide less than adequate amounts of
folate, therefore supplementary FA may be required to ensure a fetus is
optimally protected. Use of such supplements may be influenced by many
maternal factors, including age, education, income, smoking, employment,
and mother's birth outside Canada. (3)
Public health strategies for optimizing FA intake in women of
childbearing potential involve two interrelated components: improving
awareness and knowledge concerning the benefits of FA; and increasing
the proportion of women who take supplements prior to conception. In
order to facilitate such activities in Canada, this report uses data
from the Canadian Maternity Experiences Survey (MES) to identify factors
associated with prior awareness of FA benefits, and those related to use
among those who were considered knowledgeable.
METHODS
The MES was developed and implemented by the Public Health Agency
of Canada (PHAC). The primary objective of the survey was to provide
representative, pan-Canadian data on women's experiences during
pregnancy, birth and the postpartum period.
The following description of the MES is taken from Dzakpasu et al.
(2008) and further details on the survey's methods are available
there. (4) Interviews were conducted primarily by telephone between
October 23, 2006 and January 31, 2007. Most (96.9%) women were
interviewed at 5 to 9 months postpartum, with the timing ranging from
(5) to 14 months. Interviews were conducted in the participant's
first language; languages included English, French and 13 non-official
languages.
Birth mothers 15 years of age and older who had a singleton live
birth in Canada between November 1, 2005 and May 15, 2006 and who lived
with their infant at the time of data collection were eligible to
participate in the survey. Mothers under 15 years of age at the time of
giving birth and mothers living on First Nations reserves or living in
institutions were excluded for operational reasons. Any mother who had a
multiple birth (e.g., twins), stillbirth, suffered an infant death or
was no longer living with her baby was also excluded. A stratified,
random sample of 8,542 women was selected without replacement, using
recent births drawn from a Census-based sampling frame; of these women,
6,421 completed enough of the questionnaire to be considered respondents
for the MES study cohort. Each responding woman was assigned a sampling
weight calculated within weighting classes, which generally corresponded
to the strata used to draw the sample. Additional post-strata
information based on the mother's first language and Aboriginal
status was also used. The 6,421 respondents were thus weighted to
represent 76,508 women, which is considered a nationally representative
sample.
Women were considered to be knowledgeable if they reported
"yes" to the question "before your pregnancy, did you
know that taking folic acid before pregnancy can help prevent some birth
defects?" Women were categorized into two groups according to their
FA supplementation: "met recommended guidelines", meaning they
reported "yes" to all of the following questions: "In the
3 months before you got pregnant, did you take a multivitamin containing
folic acid or a folic acid supplement?", "Did you take it
every day?", "During the first 3 months of your pregnancy, did
you take a multivitamin containing folic acid or a folic acid
supplement?", and "Did you take it every day?"; or,
"did not meet the recommended guidelines".
Socio-demographic characteristics included self-reported age (in
years), marital status, education, ethnicity, province/territory of
residence, employment status, and country of birth (of mothers). A
variable labelled low income cut-off (LICO) was derived using a set of
criteria used by Statistics Canada that help identify an income
threshold below which a family will likely devote a larger share of its
income on the necessities of food, shelter and clothing than the average
family in Canada. This was dichotomized as "at/below LICO" and
"above LICO". Marital status categories included: single/never
married, married, living common-law, divorced, separated, widowed, and
refused. Education was based on the highest level of formal education
completed and was grouped as: less than high school, completed high
school and some post-secondary, post-secondary and university degree.
Pregnancy-related characteristics included parity
(primiparous/multiparous), pre-pregnancy smoking status (no
smoking/occasionally/daily), time to first prenatal care visit (in first
trimester/after first trimester), any pre-existing health issues and
planned or unplanned pregnancy. Planned and unplanned pregnancy was
determined by a proxy question: "Thinking back to just before you
became pregnant, would you say that you wanted to be pregnant..?"
If women answered "later" or "not at all", they were
considered to have had an unplanned pregnancy, and if women responded
"sooner" or "then", they were considered to have had
a planned pregnancy.
Data were analyzed using SPSS software for Windows, version 16.0.
(5) The statistical significance of crude comparisons of proportions was
assessed using chi-squared tests (p<0.05). Logistic regression was
used to calculate univariate and multivariate odds ratios; variance and
95% CI for various risk factors in relation to both awareness and use of
FA were calculated using 1,000 replicate bootstrap weights. The models
were adjusted for all socio-demographic and pregnancy-related factors.
RESULTS
Demographics
The weighted sample consisted of 76,508 women (based on 6,421
survey respondents). The majority of women were aged 25-29 years of age
(33.1%), followed by 30-34 (32.9%). Most of the women had post-secondary
diplomas (37.0%) or were university graduates (31.0%) and were above
LICO (72.6%). Over half the sample had already experienced a pregnancy
(54.9%), while the other women were first-time mothers (44.7%).
Folic acid awareness
Overall, 77.6% of women surveyed were aware of the benefits of
taking FA before pregnancy. Awareness increased with age, as
knowledgeable women represented 32.3% of those aged 15-19 and 77.4% of
those aged 25-29, compared to the highest frequencies of awareness,
which were seen in the 30-34 (87.0%) and the 45-49 (92.9%) age groups
(Table 1).
With respect to geographical variation, levels of awareness ranged
from 83.9% to 35.1% nationally (p<0.001), with women in the Yukon,
Nova Scotia, and Newfoundland reporting the highest levels, whereas
women living in Nunavut and the Northwest Territories were the least
knowledgeable.
There were statistically significant socio-economic differences
(p<0.001) in knowledge among women with less than high school
education, single women and women living at or below the LICO compared
to women with a university degree, married and living above the LICO.
Aboriginal women were less likely to report awareness of FA
compared to non-Aboriginal women (51.5% versus 79.6%, p<0.001). Women
who reported having an unplanned pregnancy were less likely to report
awareness of the benefits of FA than women who had a planned pregnancy
(63.1% versus 83.0%, p<0.001), even after controlling for age,
income, education and other variables (AOR 0.6; CI 0.50-0.71).
Folic acid use
Overall, 57.7% of women reported taking a multivitamin containing
FA and FA supplementation prior to becoming pregnant. Of these, 90% of
women who reported taking a multivitamin or supplement took it every
day.
The majority of women, 89.4%, reported taking FA (multivitamin or
supplement) during the first three months of pregnancy, 92.2% of whom
took it every day. Women aged 15-19 were the least likely to take FA
during their first three months of pregnancy (69.8%) compared to women
aged 35-39 (93.5%, p<0.001).
A pattern is noted among preconception FA use, similar to the trend
found in FA awareness (Table 2). Women who had less than high school
education, were high school graduates or had post-secondary education
below university level were less likely to report use than those with a
university degree (p<0.001). Women who reported living at or below
the LICO also reported less use than those reporting being above the
LICO (p<0.001). Women who were employed during their pregnancy
reported higher use than those who were unemployed (p<0.001).
Provincial variations were noted in FA use prior to pregnancy and
during the first trimester of pregnancy. Pre-pregnancy use ranged from
16.1% in Nunavut to 67.5% in Yukon (p<0.001). Similarly, women in
Nunavut reported the least use in the first three months of pregnancy
(51.5%), while women in the Yukon reported the highest rate (98.7%,
p<0.001).
Non-Aboriginal women reported more FA use in pre-pregnancy and
during their first trimester than Aboriginal women (58.9% versus 35.3%,
and 90.1% versus 79.8%, respectively; p<0.001).
Folic acid awareness versus use
Despite their awareness of the benefits of FA, only 68.8% of
knowledgeable women actually took an FA-containing supplement before
becoming pregnant. After controlling for age, parity, LICO, education
and other factors, there were still clear socio-economic differences
among those knowledgeable women who did not use FA in the preconception
period compared to those who did (Table 3).
A trend was observed between education and FA use. Women who
reported having less than high school education were less likely to use
FA (AOR 0.45; CI 0.33-0.62) compared to women with a university degree.
This relationship was also noted between employment and reported LICO.
Women who were unemployed and those who lived at or below the LICO were
less likely to report FA use in comparison to women who were employed
and lived above the LICO (AOR 0.49; CI 0.41-0.58). Being a first-time
mother increased the likelihood of use (2.1 times (CI 1.5-3.0) more
likely to use FA), even after controlling for a myriad of potential
confounding variables, including unplanned pregnancy (Table 3). In
general, among knowledgeable women, those whose pregnancies were
unplanned were significantly less likely to use FA (AOR 0.19; CI
0.13-0.27).
There were statistically significant age differences among
knowledgeable women who did not take FA. Women aged 15-19 (AOR 0.22; CI
0.12-0.41) and 20-24 (AOR 0.41; CI 0.32-0.52) reported less FA use prior
to becoming pregnant, compared to those aged 30-34 (reference group). No
significant differences were noted among women older than the reference
group.
Regional differences were noted in the distribution of
knowledgeable women; however, once adjusted for the potential
confounding variables, these differences were no longer significant.
Nunavut reported the least FA use (AOR 0.56; CI 0.22-1.4) while women in
Yukon reported the most (AOR 1.1; CI 0.56-2.0). Aboriginal women were
less likely to report FA use (AOR 0.51; CI 0.38-0.68) compared to
non-Aboriginal women.
Awareness versus use according to the national recommended
guidelines
Although 68.8% of knowledgeable women took FA, only 49.2% of the
total sample followed the national guidelines for optimal use, which
include daily supplementation prior to conception and during the first
three months of pregnancy.
Similar to the trends noted above, there were statistically
significant differences in frequency of optimal use among women aware of
the benefits of FA (Table 4). With regard to age, knowledgeable women
15-19 (AOR 0.12; CI 0.03-0.47), 20-24 (AOR 0.24; CI 0.16-0.37) and 25-29
years (AOR 0.52; CI 0.38-0.71) were less likely to use FA optimally
compared to women aged 30-34 (reference group). With respect to any
socio-demographic factor, women who made up the largest proportion of
those who supplemented according to the recommended guidelines reported
having a university degree (69.0%). Women with lower levels of education
reported significantly less optimal use (p<0.001). Similar to the
above-noted trends, women who reported living above the LICO and
employed women reported optimal supplementation more than their
counterparts (p<0.001).
Provincial variation also existed, even after controlling for
potential confounding variables. Optimal use among knowledgeable women
ranged from a low of 28.6% in Nunavut to a high of 64.7% in Yukon, with
significant differences noted in Quebec (AOR 0.62; CI 0.39-0.99) and
British Columbia (AOR 0.61; CI 0.41-0.92). Knowledgeable non-Aboriginal
women reported more FA use according to the recommended guidelines than
knowledgeable Aboriginal women (60.2% versus 39.4%, AOR 0.39; CI
0.22-0.69).
Last, knowledgeable women experiencing a first pregnancy were two
times more likely to report having supplemented optimally, which
resulted in the strongest predictor of ideal FA use (AOR, 2.0; CI
1.53-2.60; p<0.001), even after controlling for potential
confounders, including planned pregnancy.
DISCUSSION
The data from the MES revealed that less than half of all Canadian
women adhered to the national recommended guidelines for FA
supplementation, including daily supplementation before conception and
during the first three months of pregnancy. This study identified
several maternal socio-economic factors that may influence whether women
supplement optimally, if at all. Consistent with most public health
literature, the data indicated that women who were under 25 years, had
less than a university education and were at or below the low income
cut-off score, were less likely to have knowledge of FA benefits, and
were less likely to report supplement use prior to conception.
Although the majority of women in our sample understood that FA
supplementation could help prevent NTDs, approximately one quarter were
unaware of this information. The first Canadian guidelines for use of FA
supplementation at levels of 0.4 mg/day for all low-risk women of
childbearing potential were published in 1993. (6) Previous research
showed that a lack of awareness of the relationship between FA and NTD
and failure to use supplements subsequently remained a major problem. A
survey of 123 women attending a medical genetics clinic in Montreal in
1994 documented that only 18% were aware of the association between FA
and NTD, and few (18%) were taking supplements regularly. (70 A further
study of 342 women attending a similar clinic in Ottawa was carried out
in 1996. A high proportion of these (81%) were aware of FA, but only
26.3% had taken FA early enough before pregnancy to be effective. (7)
Our results show that, although the majority of women reported
knowledge of FA, the percentage who were supplementing according to
national guidelines was less than 50%. Similar findings have been
observed elsewhere in Canada. For example, a study done in the
Chaudiere-Appalaches region of Quebec (8) evaluated a health promotion
intervention in two phases in 1999 and 2001. The proportion of women
identifying that FA was important for NTD risk reduction did increase
significantly between the two phases of the project, from 62.0% (CI 95%
57.3-66.7%) to 70.9% (65.9-75.9%). However, this increase in knowledge
did not translate into a marked increase in women using FA. Adequate
periconceptional FA use was reported by 26.1% of women in phase 1 and by
31.6% after the intervention (p<0.05). (8)
While some Canadian studies prior to the MES explored factors
relating demographic and pregnancy-related factors with appropriate use
of FA supplementation, few documented their impact on knowledge and
fewer still did so in the context of multivariate analysis. Women's
age was an important factor, with younger women--especially those under
20 years (9)--being significantly less aware. A large Slone Epidemiology
Study found no relationship with age once adjustments were made for
confounding factors such as education, ethnicity, income, parity and
planned pregnancy. (10) Our study, however, demonstrated that age was an
independent predictor of FA awareness and use, even after controlling
for education, income, parity, marital status and planned pregnancy,
among others.
Women's education level was an important independent variable
in many studies, and knowledge, not unexpectedly, was highest among
those with post-secondary qualifications and lowest among those who had
not completed high school. (7-9,11) Our study supports these findings,
as a linear relationship was noted among FA use and awareness and level
of education. Those with university degrees made up the largest group of
women supplementing pre-conceptionally and according to the national
recommended guidelines.
With respect to geography, the MES was the first to document
knowledge across the country. Previously, rates of awareness of FA had
been noted to be lower in rural areas and small cities than in large
population centres, but there was considerable variation.12 The
geographic variability in both use and knowledge has been highlighted,
particularly for Northern Canada. Women in Nunavut reported the least
knowledge and use of FA. Furthermore, Aboriginal women reported less
knowledge and use of FA compared to non-Aboriginal women in Canada. The
survey did not interview Aboriginal women on reserve; therefore the
results are limited by way of knowing if similar patterns exist
elsewhere in Canada.
Last, although the majority of women were aware of the benefits of
supplementing FA in their diets, only 57.7% of women were supplementing
prior to becoming pregnant and less than half of all women were
supplementing according to the Canadian recommended guidelines. As all
women were interviewed postpartum, there may be recall issues in terms
of knowledge of folic acid (i.e., they may have learned this information
after they found out they were pregnant) or social desirability bias, as
all data were self-reported (the proportion of knowledgeable women may
be lower than reported).
By evaluating the characteristics of women who understood the
benefits of FA, we have been able to identify several socio-demographic
factors influencing the translation of this knowledge into actual
supplement use. This information can be used to tailor specific
interventions to target populations (i.e., younger women, Aboriginal
women). However, these data indicate that knowledge alone is not enough
to increase supplementation in Canadian women. An opportunity to hear
women's voices may provide important messages with respect to FA
supplementation and the potential approaches that could enhance its use,
particularly for women who have already experienced a pregnancy.
CONCLUSIONS
This study documents findings that are consistent with other
literature on FA awareness, and presents new information that can be
used for public health interventions. Although most women surveyed in
the MES understood the benefits of FA supplementation, a little over a
third of them did not take FA supplements prior to becoming pregnant,
and less than half supplemented according to national guidelines.
Socio-economic factors are highlighted as potential foci for public
health interventions to increase awareness and use of FA. Having a first
pregnancy seems to be a predictor of supplementation, but not for
subsequent pregnancies. Knowledge is still imperfect and more needs to
be done to increase awareness, especially among certain population
groups such as younger women and those with lower socio-economic status.
Unplanned pregnancy is still a major impediment and emphasizes the need
for promotion of regular and consistent use: if you can conceive, you
should be taking supplements. Issues of non-compliance, such as
financial barriers or concerns about the safety of FA, need to be
acknowledged and addressed and form the basis for subsequent qualitative
research studies.
Received: July 18, 2013
Accepted: November 14, 2013
Acknowledgements: The authors thank the members of the Maternal
Infant Health Section for their expertise in reviewing the manuscript
and providing invaluable feedback.
Conflict of Interest: None to declare.
REFERENCES
(1.) Public Health Agency of Canada. Congenital Anomalies in Canada
2013: A Perinatal Health Surveillance Report. Ottawa, ON, 2013. ISBN:
978-1-100222259-2.
(2.) Folate status of the population in the Canadian Health
Measures Survey (CMAJ (2011)). CMAJ 2011;183(13):1519.
(3.) Miller EC, Liu N, Wen SW, Walker M. Why do Canadian women fail
to achieve optimal pre-conceptional folic acid supplementation? An
observational study. J Obstet Gynaecol Can 2011;33(11):1116-23.
(4.) Dzakpasu S, Kaczorowski J, Chalmers B, Heaman M, Duggan J,
Neusy E. The Canadian Maternity Experiences Survey: Design and methods.
JOGC 2008;30(3):207-16.
(5.) SPSS Inc. Released 2007. SPSS for Windows, Version 16.0.
Chicago, SPSS Inc.
(6.) Van Allen MI, Fraser FC, Dallaire L, Allanson J, McLeod DR,
Andermann E, et al. Recommendations on the use of folic acid
supplementation to prevent the recurrence of neural tube defects. CMAJ
1993;149(9):1239-43.
(7.) Fraser FC. Folic acid and neural tube defects. CMAJ
1995;152(9):1380-81.
(8.) Dawson LE, Hunter AGW. Low rate of adequate folic acid
supplementation in well-educated women of high socioeconomic status
attending a genetics clinic. CMAJ2001;164(8):1149-50.
(9.) Neimanis IM, Paterson JM, Bain E. Preventing neural tube
defects: Survey of preconceptional use of folic acid. Can Fam Phys
1999;45(JUL.):1717-22.
(10.) Public Health Agency of Canada. Evaluation of food
fortification with folic acid for primary prevention of neural tube
defects. 2004. Available at:
http://www.hc-sc.gc.ca/fn-an/pubs/nutrition/folate-eng.php (Accessed
October 1, 2013).
(11.) Belanger M-R, Gregoire J. Periconceptional folic acid intake:
Evaluation of a promotional program. Can J Diet Pract Res
2003;64(4):189-94.
(12.) De Jong-Van Den Berg LTW, Hernandez-Diaz S, Werler MM, Louik
C, Mitchell AA. Trends and predictors of folic acid awareness and
periconceptional use in pregnant women. Am J Obstet Gynecol
2005;192(1):121-28.
Chantal R.M. Nelson, PhD, [1] Juan Andres Leon, MD, [1] Jane Evans,
PhD [2]
Author Affiliations
[1.] Canadian Perinatal Surveillance System, Public Health Agency
of Canada, Ottawa, ON
[2.] Medical Genetics Research Group, University of Manitoba,
Winnipeg, MB Correspondence: Dr. Chantal Nelson, Maternal and Infant
Health Section, Public Health Agency of Canada, 785 Carling Ave A/L:
6804A, Ottawa, ON K1A 0K9, E-mail: chantal.nelson@phac-aspc.gc.ca
Table 1. Percent of women reporting folic acid awareness in
relation to selected factors
Factor (%) Crude OR
n=76,508 (95% CI)
Province
NL 83.2 1.4 (0.99-1.9)
PEI 77.6 1.0 (0.71-1.5)
NS 83.7 1.5 (1.1-2.0)
NB 77.3 0.95 (0.71-1.3)
QC 77.0 1.0 (0.8-1.1)
ON 78.3 1
MB 72.4 0.73 (0.6-0.9)
SK 77.9 1.0 (0.8-1.3)
AB 76.7 0.90 (0.7-1.2)
BC 80.5 1.2 (0.9-1.5)
YK 83.9 1.5 (0.7-2.9)
NT 54.3 0.38 (0.2-0.6)
NU 35.1 0.15 (0.09-0.2)
Age group (years)
15-19 32.3 0.07 (0.05-0.099)
20-24 50.5 0.15 (0.13-0.18)
25-29 77.4 0.51 (0.44-0.61)
30-34 87.0 1
35-39 84.8 0.84 (0.68-1.02)
40-44 81.0 0.64 (0.45-0.92)
45-49 92.9 1.95 (0.25-14.9)
Employment
Employed 77.6 1
Unemployed 58.8 0.52 (0.46-0.60)
Maternal education
<high school 43.2 0.10 (0.08-0.12)
High school and some 65.5 0.25 (0.21-0.29)
post-secondary
Post-secondary 81.6 0.58 (0.49-0.68)
University degree 89.8 1
Low income cut-off
At or below LICO 59.2 0.33 (0.29-0.37)
Above LICO 84.5 1
Smoking 3 months prior to pregnancy
Smoked daily or occasionally 63.5 0.33 (0.29-0.37)
Non-smoker 81.9 1
Country of birth
Canada 80.3 1
Other 67.1 0.44 (0.38-0.50)
First prenatal care visit
1st trimester 78.9 1
After 1st trimester 60.8 0.33 (0.27-0.40)
Aboriginal status
Aboriginal 51.5 0.33 (0.27-0.41)
Non-Aboriginal 79.6 1
Pre-existing health issue
Existing condition 75.9 0.89 (0.78-0.99)
No medical condition 72.8 1
Parity
Primiparous 72.2 0.59 (0.56-0.66)
Multiparous 81.6 1
Planned pregnancy
Planned 83.0 1
Unplanned 63.1 0.4 (0.3-0.4)
Marital status
Single, never married 49.8 0.20 (0.16-0.24)
Married 83.5 1
Common-law 71.5 0.50 (0.43-0.57)
Separated 63.8 0.35 (0.23-0.54)
Divorced 64.0 0.35 (0.16-0.80)
Factor Adjusted OR
n=76,508 (95% CI)
Province
NL 1.1 (0.77-1.6)
PEI 0.82 (0.55-1.2)
NS 1.2 (0.84-1.7)
NB 0.80 (0.57-1.1)
QC 0.74 (0.61-0.90)
ON 1
MB 0.74 (0.55-0.99)
SK 0.95 (0.70-1.3)
AB 0.84 (0.67-1.1)
BC 1.0 (0.81-1.3)
YK 1.3 (0.60-2.7)
NT 0.42 (0.25-0.71)
NU 0.49 (0.27-0.90)
Age group (years)
15-19 0.12 (0.08-0.17)
20-24 0.19 (0.16-0.23)
25-29 0.54 (0.45-0.64)
30-34 1
35-39 0.88 (0.71-1.1)
40-44 0.68 (0.47-0.99)
45-49 1.3 (0.16-10.0)
Employment
Employed 1
Unemployed 0.78 (0.67-0.91)
Maternal education
<high school 0.19 (0.15-0.25)
High school and some 0.31 (0.25-0.38)
post-secondary
Post-secondary 0.55 (0.46-0.66)
University degree 1
Low income cut-off
At or below LICO 0.58 (0.49-0.69)
Above LICO 1
Smoking 3 months prior to pregnancy
Smoked daily or occasionally 0.55 (0.45-0.66)
Non-smoker 1
Country of birth
Canada 1
Other 0.26 (0.22-0.31)
First prenatal care visit
1st trimester 1
After 1st trimester 0.51 (0.40-0.64)
Aboriginal status
Aboriginal 0.52 (0.41-0.67)
Non-Aboriginal 1
Pre-existing health issue
Existing condition 0.97 (0.85-1.1)
No medical condition 1
Parity
Primiparous 0.59 (0.51-0.69)
Multiparous 1
Planned pregnancy
Planned 1
Unplanned 0.6 (0.50-0.71)
Marital status
Single, never married
Married 1
Common-law
Separated
Divorced
Adjusted for all factors listed in this table.
Table 2. Folic acid use in preconception and first three
months of pregnancy in relation to selected factors
Factor 3 months First 3
n=76,508 before months of
preqnancy pregnancy
(%) (%)
Province
NL 60.2 92.2
PEI 47.9 87.4
NS 59.8 91.3
NB 58.3 92.2
QC 56.0 87.0
ON 58.6 90.5
MB 49.7 90.5
SK 56.7 90.0
AB 59.3 87.8
BC 61.3 93.9
YK 67.5 98.7
NT 45.9 80.7
NU 16.1 51.5
Age group (years)
15-19 16.1 70.5
20-24 32.2 81.9
25-29 55.0 89.9
30-34 66.5 91.8
35-39 67.5 93.3
40-44 58.8 86.5
45-49 89.0 89.0
Employment during pregnancy
Employed 61.6 90.9
Unemployed 44.8 85.3
Maternal education
<high school 29.6 73.0
High school and some post-secondary 40.6 86.0
Post-secondary 60.2 91.0
University degree 71.8 94.3
Low income cut-off
At or below LICO 34.9 80.9
Above LICO 65.4 92.5
Smoking 3 months prior to pregnancy
Smoked daily or occasionally 43.8 82.4
Non-smoker 58.7 90.1
Country of birth
Canada 61.0 90.4
Other 48.4 87.7
First prenatal care visit
Before end of 1st trimester 59.3 91.1
After 1st trimester 32.7 61.1
Aboriginal status
Aboriginal 35.3 79.8
Non-Aboriginal 58.9 90.1
Pre-existing health issue
Existing condition 56.2 88.7
No medical condition 59.2 90.4
Parity
Primiparous 59.4 91 .6
Multiparous 56.9 88.2
Planned pregnancy
Planned 68.4 92.0
Unplanned 30.5 83.7
Marital status
Single, never married 22.5 79.8
Married 65.4 91.8
Common-law 48.1 87.5
Separated 36.9 78.1
Divorced 45.8 83.2
Table 3. Folic acid use in preconception in relation to selected
factors among women who were knowledgeable of folic acid benefits
Factor (%) Crude OR (95% CI)
n=59,285
Province
NL 68.5 0.98 (0.73-1.3)
PEI 61.3 0.71 (0.50-1.0)
NS 69.0 1.0 (0.77-1.3)
NB 68.4 0.97 (0.72-1.3)
QC 67.8 0.95 (0.80-1.1)
ON 68.8 1
MB 66.7 0.90 (0.68-1.2)
SK 69.3 1.0 (0.78-1.4)
AB 69.7 1.1 (0.84-1.3)
BC 72.4 1.2 (0.93-1.5)
YK 71.2 1.2 (0.64-2.2)
NT 59.1 0.76 (0.43-1.4)
NU 33.3 0.23 (0.10-.51)
Age group (years)
15-19 26.6 0.13 (0.08-0.24)
20-24 44.0 0.29 (0.23-0.36)
25-29 66.3 0.73 (0.63-0.84)
30-34 73.0 1
35-39 75.9 1.2 (0.97-1.4)
40-44 70.9 0.90 (0.64-1.3)
45-49 92.3 4.4 (0.58-3.42)
Employment during pregnancy
Employed 71.2 1
Unemployed 56.2 0.52 (0.45-0.60)
Maternal education
<high school 42.0 0.20 (0.15-0.26)
High school and some post-secondary 52.7 0.31 (0.26-0.36)
Post-secondary 69.3 0.62 (0.54-0.72)
University degree 78.4 1
Low income cut-off
At or below LICO 45.1 0.30 (0.25-0.35)
Above LICO 73.5 1
Smoking 3 months prior to pregnancy
Smoked daily or occasionally 41.0 0.31 (0.26-0.37)
Non-smoker 71.5 1
Country of birth
Canada 69.6 1
Other 62.7 0.74 (0.63-0.86)
First prenatal care visit
Before end of 1st trimester 69.7 1
After 1st trimester 44.3 0.33 (0.25-0.44)
Aboriginal status
Aboriginal 47.8 0.41 (0.31-0.53)
Non-Aboriginal 69.5 1
Pre-existing health issue
Existing condition 67.2 0.90 (0.80-1.0)
No medical condition 69.4 1
Parity
Primiparous 74.2 2.4 (1.8-3.2)
Multiparous 64.4 1
Planned pregnancy
Planned 83.3 1
Unplanned 63.5 0.16 (0.12-0.23)
Marital status
Single, never married 28.6 0.13 (0.10-0.18)
Married 75.1 1
Common-law 58.4 0.47 (0.40-0.54)
Separated 50.0 0.33 (0.20-0.55)
Divorced 56.2 0.43 (0.16-1.1)
Factor Adjusted OR (95% CI)
n=59,285
Province
NL 1.0 (0.73-1.4)
PEI 0.74 (0.51-1.0)
NS 1.0 (0.75-1.4)
NB 1.0 (0.73-1.4)
QC 0.93 (0.77-1.1)
ON 1
MB 1.0 (0.76-1.4)
SK 1.2 (0.91-1.7)
AB 1.1 (0.88-1.4)
BC 1.2 (0.94-1.5)
YK 1.2 (0.61-2.3)
NT 1.1 (0.56-2.0)
NU 0.56 (0.22-1.4)
Age group (years)
15-19 0.22 (0.12-0.41)
20-24 0.41 (0.32-0.52)
25-29 0.77 (0.66-0.91)
30-34 1
35-39 1.2 (1.0-1.5)
40-44 1.1 (0.76-1.6)
45-49 5.1 (0.64-4.1)
Employment during pregnancy
Employed 1
Unemployed 0.80 (0.67-0.93)
Maternal education
<high school 0.45 (0.33-0.62)
High school and some post-secondary 0.46 (0.38-0.55)
Post-secondary 0.75 (0.64-0.87)
University degree 1
Low income cut-off
At or below LICO 0.49 (0.41-0.58)
Above LICO 1
Smoking 3 months prior to pregnancy
Smoked daily or occasionally 0.41 (0.34-0.49)
Non-smoker 1
Country of birth
Canada 1
Other 0.59 (0.49-0.70)
First prenatal care visit
Before end of 1st trimester 1
After 1st trimester 0.41 (0.30-0.55)
Aboriginal status
Aboriginal 0.51 (0.38-0.68)
Non-Aboriginal 1
Pre-existing health issue
Existing condition 0.88 (0.77-1.0)
No medical condition 1
Parity
Primiparous 2.1 (1.5-3.0)
Multiparous 1
Planned pregnancy
Planned 1
Unplanned 0.19 (0.13-0.27)
Marital status
Single, never married 0.18 (0.14-0.25)
Married 1
Common-law 0.55 (0.47-0.63)
Separated 0.40 (0.24-0.68)
Divorced 0.45 (0.16-1.5)
Adjusted for all factors listed in this table.
Table 4. Knowledgeable women who supplemented with folic acid
according to recommended guidelines in relation to selected factors
Factor (%) Crude OR (95% CI)
n=59,285
Province
NL 62.8 1.1 (0.86-1.42)
PEI 52.1 0.65 (0.48-0.89)
NS 60.4 1.0 (0.82-1.30)
NB 58.8 0.88 (0.69-1.13)
QC 56.8 0.82 (0.71-0.94)
ON 60.8 1
MB 55.9 0.68 (0.54-0.86)
SK 61.3 0.93 (0.74-1.18)
AB 59.8 0.91 (0.76-1.08)
BC 61.1 1.0 (0.85-1.22)
YK 64.7 1.2 (0.72-2.0)
NT 52.9 0.56 (0.36-0.87)
NU 28.6 0.12 (0.06-0.23)
Age group (years)
15-19 20.3 0.08 (0.05-0.13)
20-24 34.5 0.21 (0.18-0.26)
25-29 57.6 0.67 (0.59-0.75)
30-34 64.0 1
35-39 65.6 1.1 (0.91-1.22)
40-44 61.1 0.80 (0.34-2.85)
45-49 61.5 0.99 (0.34-2.86)
Employment during pregnancy
Employed 62.0 1
Unemployed 47.1 0.53 (0.47-0.60)
Maternal education
<high school 32.1 0.14 (0.11-0.17)
High school and some post-secondary 44.2 0.27 (0.23-0.31)
Post-secondary 60.0 0.60 (0.53-0.68)
University degree 69.0 1
Low income cut-off
At or below LICO 35.9 0.26 (0.23-0.30)
Above LICO 64.2 1
Smoking 3 months prior to pregnancy
Smoked daily or occasionally 44.0 0.46 (0.37-0.58)
Non-smoker 60.0 1
Country of birth
Canada 60.3 1
Other 53.7 0.67 (0.59-0.76)
First prenatal care visit
Before end of 1st trimester 67.6 1
After 1st trimester 67.8 1.0 (0.79-1.29)
Aboriginal status
Aboriginal 39.4 0.33 (0.27-0.42)
Non-Aboriginal 60.2 1
Pre-existing health issue
Existing condition 58.3 0.92 (0.83-1.01)
No medical condition 59.9 1
Parity
Primiparous 67.1 1.24 (1.12-1.37)
Multiparous 53.6 1
Planned pregnancy
Planned 68.3 1
Unplanned 30.4 0.21 (0.18-0.23)
Marital status
Single, never married 22.9 0.15 (0.12-0.19)
Married 65.6 1
Common-law 49.5 0.45 (0.40-0.51)
Separated 36.7 0.26 (0.16-0.41)
Divorced 37.5 0.29 (0.12-0.69)
Factor Adjusted OR (95% CI)
n=59,285
Province
NL 1.1 (0.75-1.29)
PEI 0.54 (0.18-1.61)
NS 0.82 (0.65-2.19)
NB 0.94 (0.47-1.92)
QC 0.62 (0.39-0.99)
ON 1
MB 0.67 (0.38-1.19)
SK 1.4 (0.83-2.45)
AB 0.75 (0.50-1.14)
BC 0.61 (0.41-0.92)
YK 0.60 (0.19-1.89)
NT 0.94 (0.28-3.15)
NU 0.85 (0.21-3.62)
Age group (years)
15-19 0.12 (0.03-0.47)
20-24 0.24 (0.16-0.37)
25-29 0.52 (0.38-0.71)
30-34 1
35-39 1.1 (0.77-1.59)
40-44 0.86 (0.46-1.64)
45-49 1.02 (0.61-1.71)
Employment during pregnancy
Employed 1
Unemployed 0.98 (0.73-1.32)
Maternal education
<high school 0.25 (0.13-0.45)
High school and some post-secondary 0.40 (0.28-0.58)
Post-secondary 0.68 (0.50-0.93)
University degree 1
Low income cut-off
At or below LICO 0.60 (0.42-0.86)
Above LICO 1
Smoking 3 months prior to pregnancy
Smoked daily or occasionally 0.38 (0.22-0.65)
Non-smoker 1
Country of birth
Canada 1
Other 0.39 (0.29-0.54)
First prenatal care visit
Before end of 1st trimester 1
After 1st trimester 0.93 (0.70-1.23)
Aboriginal status
Aboriginal 0.39 (0.22-0.69)
Non-Aboriginal 1
Pre-existing health issue
Existing condition 0.97 (0.75-1.24)
No medical condition 1
Parity
Primiparous 2.0 (1.53-2.60)
Multiparous 1
Planned pregnancy
Planned 1
Unplanned 0.23 (0.17-0.31)
Marital status
Single, never married 0.27 (0.14-0.51)
Married 1
Common-law 0.44 (0.31-0.63)
Separated 0.38 (0.11-1.40)
Divorced 0.36 (0.18-1.12)
Adjusted for all factors listed in this table.